The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)
NCT06138223 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196
Last updated 2026-05-07
Summary
The survival of patients with incurable gastroesophageal cancer can extend over a year with anticancer therapy. However, the number of patients with deteriorating quality of life in this patient group steadily decreases over time during the treatment. Potentially reversible causes related to deterioration of quality of life are diminished muscle mass, physical capacity and nutritional status. Therefore, interventions that can target these in order to maintain or improve quality of life are urgently needed.
However, it is yet unknown whether improvement of physical capacity and nutritional status improves quality of life in patients with incurable gastroesophageal adenocarcinoma after failure of first-line treatment. Since these patients are in a precarious situation, the benefits and harms of a combined exercise and nutritional intervention should be carefully evaluated.Therefore this study investigates the effect of a combined exercise and nutrition intervention compared to usual care on quality of life in incurable GAC patients after progression upon first-line treatment.
A total of 196 patients with metastasized gastroesophageal cancer will be recruited and randomly allocated 1:1 to standard care or standard care plus a combined exercise and nutritional intervention.
Conditions
- GastroEsophageal Cancer
- Incurable Disease
Interventions
- OTHER
-
Exercise intervention
During 12 weeks, patients will visit twice a week a trained oncology physiotherapist for one hour per session. This training includes supervised aerobic and resistance exercises to increase aerobic condition and muscle resistance, based on their own fitness level as assessed at baseline. Additionally, physiotherapists will educate participants on how to increase their daily activity. To this end, all participants will receive an activity tracker to monitor their daily activities.
- OTHER
-
Nutrition intervention
Once every two weeks patients in the intervention group will receive a nutritional assessment and intervention by a trained dietician for optimization of their nutritional intake to improve their nutritional status, following the ESPEN guideline on nutrition in cancer patients and the national guidelines of the National Nutritionists Oncology Working Group (NNOWG; in Dutch: Landelijke Werkgroep Diëtisten Oncologie, LWDO). Moreover, an amount of 15-25 grams of protein within 1-2 hours after exercise will be advised, to prevent muscle protein breakdown and enhance muscle protein synthesis.
Sponsors & Collaborators
-
UMC Utrecht
collaborator OTHER -
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
lead OTHER
Principal Investigators
-
Hanneke van Laarhoven · Amsterdam AMC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2028-09-30
- Completion
- 2028-09-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Angiogenic Factor Expression During Fractionated Irradiation
NCT02072720 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma
NCT00230451 ·Status: COMPLETED ·Phase: PHASE2
-
Rehabilitative Strategies Following Oesophageal Cancer
NCT03314311 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
NCT00033657 ·Status: COMPLETED ·Phase: PHASE2
-
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
NCT07000253 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
NCT00938470 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
NCT01107639 ·Status: COMPLETED ·Phase: PHASE3
-
Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus
NCT00003321 ·Status: COMPLETED
-
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
NCT06872515 ·Status: RECRUITING ·Phase: NA
-
Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction
NCT00757172 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
NCT00021320 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real Dose
NCT02130011 ·Status: COMPLETED ·Phase: NA
-
Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma
NCT01404156 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
NCT00047112 ·Status: COMPLETED ·Phase: PHASE3
-
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
NCT04615013 ·Status: RECRUITING ·Phase: PHASE1
-
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer
NCT01558648 ·Status: COMPLETED
-
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
NCT00551759 ·Status: TERMINATED ·Phase: PHASE2
-
Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer
NCT00470184 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
NCT00069953 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002884 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT04046575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma
NCT03274349 ·Status: UNKNOWN ·Phase: NA
-
Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer
NCT01787006 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoradiotherapy for Advanced Esophageal Cancer
NCT02297217 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
NCT01670409 ·Status: COMPLETED ·Phase: PHASE2